Most cited papers from Hamilton Health Sciences

Hamilton Health Sciences

What are the most cited papers from Hamilton Health Sciences?

The most cited paper from Hamilton Health Sciences is "Dabigatran versus Warfarin in Patients with Atrial Fibrillation" (Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al., 2009), with 11,272 citations. Next come "Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis" (4,111) and "CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database" (3,385).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 1,004 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Dabigatran versus Warfarin in Patients with Atrial Fibrillation Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine Open access	30 Aug 2009	11,272
2	Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis Derek K. Chu et al. · The Lancet ReviewOpen access	Jun 2020	4,111
3	CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database Brian P. Alcock et al. · Nucleic Acids Research Open access	8 Oct 2019	3,385
4	Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein et al. · The Lancet Open access1,458 authors	9 Jun 2019	3,173
5	COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up Behnood Bikdeli et al. · Journal of the American College of Cardiology Open access	17 Apr 2020	2,956
6	Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study Salim Yusuf, Steven Hawken, Stephanie Ôunpuu et al. · The Lancet	Nov 2005	2,918
7	Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial John J.V. McMurray, Jan Östergren, Karl B Swedberg et al. · The Lancet	Sep 2003	2,612
8	Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer Agnes Y. Y. Lee, Mark N. Levine, Ross Ian Baker et al. · New England Journal of Medicine Open access	9 Jul 2003	2,541
9	Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease John W. Eikelboom et al. · New England Journal of Medicine Open access	27 Aug 2017	2,456
10	Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study Annika Rosengren, Steven Hawken, Stephanie Ôunpuu et al. · The Lancet	Sep 2004	2,442
11	Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study Martin James O'Donnell et al. · The Lancet Open access	16 Jul 2016	2,304
12	Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure Christopher M. O’Connor, David J. Whellan, Kerry L. Lee et al. · JAMA Open access	7 Apr 2009	2,197
13	Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Sanjit S. Jolly, Salim Yusuf, John A. Cairns et al. · The Lancet	Apr 2011	2,130
14	Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study Salim Yusuf et al. · The Lancet Open access	3 Sep 2019	2,054
15	Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries Clara Kayei Chow · JAMA Open access	3 Sep 2013	2,052
16	Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction Barry M. Massie, Peter E. Carson, John J.V. McMurray et al. · New England Journal of Medicine Open access	11 Nov 2008	1,969
17	Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Cardiogenics et al. · Nature Genetics Open access167 authors	6 Mar 2011	1,959
18	Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study Darryl P. Leong et al. · The Lancet Open access	13 May 2015	1,905
19	Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Marc Alan Pfeffer, Karl B Swedberg, Christopher Bull Granger et al. · The Lancet	Sep 2003	1,898
20	CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials David Moher, Sally Hopewell, Kenneth F. Schulz et al. · Journal of Clinical Epidemiology Open access	26 Mar 2010	1,888
21	Interpretation of the evidence for the efficacy and safety of statin therapy Rory Collins et al. · The Lancet Open access	12 Sep 2016	1,883
22	Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure ANTHONY S.L. TANG, George A. Wells, Mario Talajic et al. · New England Journal of Medicine	14 Nov 2010	1,870
23	The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice Přemysl Berčík, Emmanuel Denou, Josh Collins et al. · Gastroenterology Open access	2 May 2011	1,766
24	Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators · New England Journal of Medicine Open access	12 Mar 2006	1,736
25	Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Christopher Bull Granger, John J.V. McMurray, Salim Yusuf et al. · The Lancet	Sep 2003	1,692
26	A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients Meyer Michel Samama, Alexander Thomas Cohen, Jean‐Yves Darmon et al. · New England Journal of Medicine Open access	9 Sep 1999	1,607
27	Transmission Dynamics and Control of Severe Acute Respiratory Syndrome Marc Lipsitch, Ted Cohen, Ben Symons Cooper et al. · Science Open access	27 May 2003	1,605
28	Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients Marcus D Flather, Salim Yusuf, Lars Køber et al. · The Lancet	May 2000	1,595
29	Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials Naveed A. Sattar, Matthew M.Y. Lee, Søren Lund Kristensen et al. · The Lancet Diabetes & Endocrinology ReviewOpen access	20 Aug 2021	1,590
30	Dabigatran versus Warfarin in Patients with Mechanical Heart Valves John W. Eikelboom, Stuart J. Connolly, Martina Brueckmann et al. · New England Journal of Medicine	Sep 2013	1,514
31	Pharmacological Treatment of Parkinson Disease Barbara S. Connolly, Anthony E. Lang · JAMA	22 Apr 2014	1,511
32	Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies Russell J. de Souza, Andrew Mente, Adriana Maroleanu et al. · BMJ ReviewOpen access	11 Aug 2015	1,448
33	The Canadian Occupational Performance Measure: An Outcome Measure for Occupational Therapy Mary Law, Sue Baptiste, MaryAnn McColl et al. · Canadian Journal of Occupational Therapy	Apr 1990	1,443
34	The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study Scott Alexander Lear et al. · The Lancet Open access	22 Sep 2017	1,390
35	Diversity of antimicrobial peptides and their mechanisms of action Richard M. Epand, Hans J. Vogel · Biochimica et Biophysica Acta (BBA) - Biomembranes Open access	Dec 1999	1,364
36	A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease Andrew Mente, Lawrence de Koning, Harry S. Shannon et al. · Archives of Internal Medicine	13 Apr 2009	1,289
37	Intensive glucose control and macrovascular outcomes in type 2 diabetes Fiona Turnbull, Carlos Abraira, Robert J. Anderson et al. · Diabetologia	4 Aug 2009	1,208
38	Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer The HOPE and HOPE-TOO Trial Investigators · JAMA Open access	15 Mar 2005	1,208
39	2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary] David C.W. Lau, James D. Douketis, Katherine Mary Morrison et al. · Canadian Medical Association Journal Open access	9 Apr 2007	1,169
40	The Wingate Anaerobic Test Oded Bar‐Or · Sports Medicine	1987	1,163
41	Long-term Psychological and Occupational Effects of Providing Hospital Healthcare during SARS Outbreak Robert Maunder et al. · Emerging infectious diseases Open access	2006	1,163
42	A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery Dean A. Fergusson, Paul C. Hébert, C. David Mazer et al. · New England Journal of Medicine Open access	14 May 2008	1,156
43	American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts Santhi Swaroop Vege, Barry S. Ziring, Rajeev Kumar Jain et al. · Gastroenterology Open access	21 Mar 2015	1,155
44	Interventions to Enhance Patient Adherence to Medication Prescriptions Heather McDonald, Amit X. Garg, Robert Brian Haynes · JAMA	11 Dec 2002	1,141
45	Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials Stuart J. Connolly · European Heart Journal Review	15 Dec 2000	1,130
46	A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism Clive Kearon et al. · New England Journal of Medicine Open access	25 Mar 1999	1,078
47	The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys Laura Helena Andrade, Jorge Javier Caraveo-Anduaga, Patricia A. Berglund et al. · International Journal of Methods in Psychiatric Research Open access	Feb 2003	1,078
48	THE GROSS MOTOR FUNCTION MEASURE: A MEANS TO EVALUATE THE EFFECTS OF PHYSICAL THERAPY Dianne J Russell, Peter Rosenbaum, David T. Cadman et al. · Developmental Medicine & Child Neurology	Jun 1989	1,078
49	Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials Sanjit S. Jolly, Shoaib Amlani, Martial Hamon et al. · American Heart Journal Review	4 Nov 2008	1,075
50	Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies Tali Cukierman, Hertzel C. Gerstein, Jeff D. Williamson · Diabetologia	8 Nov 2005	1,062

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.